Park Ha Biological Technology is trading 10.94% down at $2.87 in pre-market, with the immediate catalyst unconfirmed.

  • The stock closed at $3.22 on August 6, when it surged 875.46%.
  • The company’s 1-for-8 reverse split became effective August 6, with split-adjusted trading beginning that session.
  • Nasdaq confirmed the reverse split and CUSIP change; no reliable August 7 announcement directly explains the decline.